Phase 1 Study of Multikine in the Treatment of Perianal Warts
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2016
Price : $35 *
At a glance
- Drugs Buffy coat interleukins (Primary)
- Indications Anal cancer; Anal dysplasia; Anal intraepithelial neoplasia; Genital warts
- Focus Therapeutic Use
- Sponsors CEL-SCI Corporation
- 24 Aug 2016 Last checked against ClinicalTrials.gov record.
- 17 Aug 2016 Status changed from recruiting to discontinued.
- 09 Feb 2016 According to CEL-SCI media release, this study in expected to complete in the second half of 2016.